Inozyme Pharma, Inc(NASDAQ:INZY) 
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare gen...
Website: http://www.inozyme.com
Founded: 2015
CEO: Axel Bolte
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-12-30
P
O 2.89
H 2.90
L 2.78
C 2.82
V 273,041
10EMA 2.82
20EMA 2.82
60EMA 2.82
120EMA 2.82
250EMA 2.82